Skip to main content
. 2021 Mar 24;7(13):eabc9992. doi: 10.1126/sciadv.abc9992

Fig. 4. The hemostatic activity of CHI-C in the blood of liver transplant patients with coagulopathy.

Fig. 4

TEG tracings with measured quantitative parameters showing the hemostatic activity of CHI-C solution in the blood of a patient exhibiting a normal coagulation state (A) and patients exhibiting various coagulopathic states (B to D). (E and F) The hemostatic ability of CHI-C sponges for liver bleeding caused by a liver resection in anticoagulated rabbit models [(E) warfarin treated and (F) clopidogrel treated].